Results 91 to 100 of about 45,910 (249)

Immunoglobulin E-Mediated Autoimmunity [PDF]

, 2018
The study of autoimmunity mediated by immunoglobulin E (IgE) autoantibodies, which may be termed autoallergy, is in its infancy. It is now recognized that systemic lupus erythematosus, bullous pemphigoid (BP), and chronic urticaria, both spontaneous and ...
Altrichter, Sabine, Church, Martin K., Maurer, Marcus, Metz, Martin, Scheffel, Jörg, Schmetzer, Oliver   +5 more
core   +1 more source

Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl, Henning Schliephake, Simon Storgård Jensen   +2 more
wiley   +1 more source

Pemphigoid vegetans in childhood: A case report and short review of literature

Indian Journal of Dermatology, 2015
Pemphigoid vegetans is a very rare type of bullous pemphigoid which usually affects the elderly and has not been reported in children. It shows a clinical resemblance to pemphigus vegetans but has distinct histological and immunopathological features of ...
Yasmeen Khatib, Meena Makhija, Richa D Patel, Gayatri Karad   +3 more
doaj   +1 more source

Autoimmuunsed villilised haigused [PDF]

, 2006
Villiliste haiguste rühma patogeneetiliseks aluseks on autoantikehade tekkimine epi der mise või dermoepidermaalse ühendusjoone normaalsete komponentide vastu. Kuigi hai gu sed erinevad omavahel haigete keskmise vanuse, kliinilise pildi ja histoloogilise
Kaur, Sirje, Pärna, Ene
core   +2 more sources

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development

International Journal of Dermatology, EarlyView.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease, with a rising incidence in the elderly. BP is associated with multiple triggering factors, including drug exposure. However, evidence in this respect is limited, and the underlying immune mechanisms remain unknown.
Belen de Nicolas‐Ruanes, Carlos Fernandez‐Lozano, Patricia Gutierrez‐Canales, Asuncion Ballester‐Martinez, Natalia Rodriguez‐Otero, Javier Martinez‐Botas, Belén de la Hoz Caballer, Ana Andres‐Martin, Emilio Solano‐Solares, Maria Esther Gomez‐Salazar Lopez‐Silanes, Laura Gisella Diaz‐Montalvo, Diana M. Arrebola, Vivian Lizeth Stewart‐Delcid, Emilio Garcia‐Mouronte, Carlos Azcarraga‐Llobet, Emilio Berna‐Rico, Sonia Ortega‐Sanchez, Montserrat Fernandez‐Guarino   +17 more
wiley   +1 more source

Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients

Acta Dermato-Venereologica
Drug-associated bullous pemphigoid has been shown to follow long-term gliptin (dipeptidyl-peptidase 4 inhibitors) intake. This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes.
Dana Shalmon, Efrat Bar-Ilan, Alon Peled, Shamir Geller, Jonathan Bar, Naama Schwartz, Eli Sprecher, Mor Pavlovsky   +7 more
doaj   +1 more source

Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus

Journal of the European Academy of Dermatology and Venereology, 2020
The BIOCHIP is a novel multiplex indirect immunofluorescence technique used in the serological diagnosis of bullous pemphigoid and pemphigus. The BIOCHIP method combines the screening of autoantibodies and target antigen‐specific substrates in a single ...
Anes Yang, Rachel Xuan, W. Melbourne, K. Tran, D. Murrell   +4 more
semanticscholar   +1 more source

Urticarial Plaques With Vesicles in a Young Hispanic Woman

JEADV Clinical Practice, EarlyView.
Valeria Olvera‐Rodríguez, Gerardo González‐Martínez, Sonia Chávez‐Álvarez, Bárbara Sáenz‐Ibarra, Minerva Gómez‐Flores, Jorge Ocampo‐Candiani, Erika Alba‐Rojas   +6 more
wiley   +1 more source

Dupilumab for the Treatment of Cutaneous Immune‐Related Adverse Events: A Systematic Review

International Journal of Dermatology, EarlyView.
ABSTRACT The emergence of immune checkpoint inhibitors has revolutionized the landscape of cancer treatment in the modern era. However, cutaneous immune‐related adverse events (cirAEs) are common, significantly affecting patients' quality of life and often leading to treatment discontinuation, which may compromise oncological outcomes.
Ioannis‐Alexios Koumprentziotis, Aikaterini Niforou, Antonios Tsimpidakis, Christos Nikolaou, Alexander Stratigos, Vasiliki Nikolaou   +5 more
wiley   +1 more source

IgE autoantibodies in serum and skin of non‐bullous and bullous pemphigoid patients

Journal of the European Academy of Dermatology and Venereology, 2020
Non‐bullous pemphigoid (NBP) is a pemphigoid variant which frequently resembles other pruritic skin diseases. In contrast with bullous pemphigoid (BP), blisters are absent.
A. Lamberts, N. Kotnik, G. Diercks, J. Meijer, G. Zenzo, H. Pas, M. Jonkman, B. Gibbs, U. Raap, B. Horváth   +9 more
semanticscholar   +1 more source